Combined Effects of Simvastatin and Enamel Matrix Derivative on Odontoblastic Differentiation of Human Dental Pulp Cells

详细信息    查看全文

• 作者：Lorena Karanxha ; DDS^&lowast ; ; Su-Jung Park ; DDS ; MSD^&lowast ; ; Won-Jun Son ; DDS ; MSD ; PhD^&dagger ; ; Jacques E. Nö ; r ; DDS ; MSD ; PhD^&Dagger ; ; ^§ ; ; ^‖ ; Kyung-San Min ; DDS ; MSD ; PhD^¶ ; ; ^{endomin@gmail.com" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Combination ; enamel matrix derivative ; extracellular signal&ndash ; regulated kinase ; simvastatin ; odontoblastic
• 刊名：Journal of Endodontics
• 出版年：2013
• 出版时间：January 2013
• 年：2013
• 卷：39
• 期：1
• 页码：76-82
• 全文大小：504 K

文摘

We previously reported that simvastatin and enamel matrix derivative (EMD) have a dentinogenic effect. However, there is little information about the combined effects of these 2 agents on odontoblastic differentiation. The aim of this study was to investigate the effects of combined treatment with simvastatin and EMD on odontoblastic differentiation of human dental pulp cells (hDPCs). This study further explored the role of extracellular signal-regulated kinase (ERK) as a target and mediator of the differentiation induced by simvastatin in hDPCs.

Methods

The odontoblastic differentiation was analyzed by alkaline phosphatase activity, real-time polymerase chain reaction (PCR) for odontoblastic/osteoblastic markers (ie, dentin sialophosphoprotein, dentin matrix protein 1, and osteonectin), and alizarin red S staining. We also explored the role of ERK signaling as a mediator of simvastatin by Western blotting and real-time PCR. The expression of osteoblast-specific transcription factors was detected by reverse-transcription PCR.

Results

The alkaline phosphatase activity and the expression of odontoblastic markers (ie, dentin sialophosphoprotein and dentin matrix protein 1) increased in simvastatin/EMD-treated cells. Mineralized nodule formation increased in EMD- and simvastatin/EMD-treated cells. Notably, the combined use of both simvastatin and EMD resulted in more potent differentiation than that observed after a single therapy. Simvastatin activated ERK phosphorylation and treatment with ERK inhibitor blocked the messenger RNA expression of odontoblastic markers. However, in simvastatin/EMD-treated cells, the expression of these genes did not decrease significantly. Compared with other groups, the EMD- and simvastatin/EMD-treated group showed a greater expression of osterix.

Conclusions

Simvastatin promotes odontoblastic differentiation of hDPCs via the ERK signaling pathway. In addition, simvastatin-induced differentiation is facilitated by co-treatment with EMD. Collectively, these results suggest a new strategy to induce odontoblastic differentiation of hDPCs.